Different superantigens interact with distinct sites in the Vbeta domain of a single T cell receptor.
Open Access
- 1 April 1996
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 183 (4) , 1437-1446
- https://doi.org/10.1084/jem.183.4.1437
Abstract
CD4 T cell receptors (TCRs) recognize antigenic peptides presented by self major histocompatibility complex (MHC) class II molecules as well as non-self MHC class II molecules. The TCRs can also recognize endogenous retroviral gene products and bacterial toxins known collectively as superantigens (SAGs) that act mainly on the Vbeta gene segment-encoded portion of the Vbeta domain; most SAGs also require MHC II class for presentation. We have studied the interaction of the TCR from a well-characterized CD4 T cell line with SAGs by mutational analysis of its Vbeta domain. This appears to separate viral (v)SAG from bacterial (b)SAG recognition. T cells having a TCR with glycine to valine mutation in amino acid residue 51 (G51V) in complementarity determining region 2 of the TCR Vbeta domain fail to respond the bSAGs staphylococcal enterotoxin B (SEB), SEC1, SEC2, and SEC3, whereas they retain the ability to respond to non-self MHC class II molecules and to foreign peptides presented by self MHC class II molecules. It is interesting to note that T cells expressing mutations of both G51V and G53D of V beta regain the response to SEB and partially that to SEC1, but do not respond to SEC2, and SEC3, suggesting that different bacterial SAGs are viewed differently by the same TCR. These results are surprising, because it has been generally believed that SAG recognition by T cells is mediated exclusively by hypervariable region 4 on the exposed, lateral face of the TCR Vbeta domain. Response to the vSAG Mtv-7 was generated by mutation in Vbeta residue 24 (N24H), confirming previously published data. These data show that the vSAG Mtv-7 and bSAGs are recognized by different regions of the TCR Vbeta domain. In addition, various bSAGs are recognized differently by the same TCR. Thus, these mutational data, combined with the crystal structure of the TCR beta chain, provide evidence for distinct recognition sites for vSAG and bSAG.Keywords
This publication has 44 references indexed in Scilit:
- Serial triggering of many T-cell receptors by a few peptide–MHC complexesNature, 1995
- T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen.The Journal of Experimental Medicine, 1993
- Identification of HLA-DR alpha chain residues critical for binding of the toxic shock syndrome toxin superantigen.The Journal of Experimental Medicine, 1992
- Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E.The Journal of Experimental Medicine, 1992
- Low Affinity Interaction of Peptide-MHC Complexes with T Cell ReceptorsScience, 1991
- The use of the polymerase chain reaction to map CD4+ T cell epitopesEuropean Journal of Immunology, 1991
- Vβ17 gene polymorphism in wild-derived mouse strains: Two amino acid substitutions in the Vβ17 region greatly alter T cell receptor specificityCell, 1990
- Superantigens interact with MHC class II molecules outside of the antigen grooveCell, 1990
- Site-directed mutagenesis by overlap extension using the polymerase chain reactionGene, 1989
- The Fab fragment of a directly activating monoclonal antibody that precipitates a disulfide-linked heterodimer from a helper T cell clone blocks activation by either allogeneic Ia or antigen and self-Ia.The Journal of Experimental Medicine, 1984